The NB.1.8.1 variant made up roughly 10.7 per cent of all global infections by late April 2025 – up from just 2.5 per cent ...

Jefferies reaffirms its Buy rating on Pfizer and sticks to a $33 target, calling the stock undervalued at $23.35. Their ...

Pharmac’s current proposal would fund only the Comirnaty vaccine, with alternative brands available solely through its Exceptional Circumstances framework. ACA believes this creates an exclusionary ...

Like a bunny boiler who refuses to die in a horror movie, the Covid jabs are back. Headlines trumpet the familiar narrative: ...

A new COVID variant - NB 1.8.1 - is creeping across the country; here are the symptoms to watch for, and vaccinations you'll ...

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty discusses two new COVID vaccines ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling ...

A UCLA professor of clinical obstetrics and gynecology says he still sees more bad outcomes in pregnant patients who have ...

While it no longer generates the sales it once did, Pfizer's coronavirus lineup remains critical to its results. The past ...